Perspective Therapeutics Updates Corporate Presentation (8-K)

What Happened
Perspective Therapeutics, Inc. (CATX) filed a Current Report on Form 8-K on October 1, 2026, to disclose an updated corporate presentation. The presentation is filed as Exhibit 99.1 and is incorporated by reference into the Form 8-K. The filing was signed by Joel Sendek, Chief Financial Officer.

Key Details

• Filing date: October 1, 2026 (Form 8-K, Item 8.01 — Other Events).
• Exhibit included: 99.1 — Corporate Presentation.
• The filing also references the Inline XBRL cover page (Exhibit 104).
• The report did not include earnings, revenue figures, executive departures/appointments, mergers, acquisitions, or financial statements beyond the presentation.

Why It Matters
An updated corporate presentation can contain refreshed information about the company’s strategy, pipeline, milestones, or investor messaging—items investors often review for context on operations and outlook. Because this 8-K does not include financial results or management changes, investors should review Exhibit 99.1 directly to see any substantive updates; absent that, there are no reported earnings, CEO/CFO changes, or transaction announcements in this filing.